Comparison of intranasal hypertonic Dead Sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis

Ear, Nose and Throat Journal

Volumn 84, Issue 7, 2005, Pages 426-430

  Cordray, Scott ^a,c   Harjo, Jim B ^a   Miner, Linda ^a,b  

^a Southern Nazarene University ^*

^b Southern Nazarene University   (United States)

^c Hillcrest Physicians Bldg   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SODIUM CHLORIDE; TRIAMCINOLONE;

ADULT; AEROSOL; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSAGE FORM; DRUG EFFICACY; FEMALE; HAY FEVER; HUMAN; MALE; MUCOCILIARY CLEARANCE; NOSE MUCOSA; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 30944446352     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130508400713     Document Type: Article

References (43)

1. Levetin E, Buck P. Hay fever plants in Oklahoma. Ann Allergy 1980;45:26-32.
2. Levetin E, Larsen-Purvis M. Tulsa Pollen Calendar. The University of Tulsa Aerobiology Laboratory.
3. Levetin E. A long-term study of winter and early spring tree pollen in the Tulsa, Oklahoma atmosphere. Aerobiologia 1998;14:21-8.
4. Levetin E, Buck P. Evidence of mountain cedar pollen in Tulsa. Ann Allergy 1986;56:295-9.
5. Kaszuba SM, Baroody FM, deTineo M, et al. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med 2001;161:2581-7.
6. Parikh A, Scadding GK, Darby Y, Baker RC. Topical corticosteroids in chronic rhinosinusitis: A randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001;39:75-9.
7. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomized controlled trials. BMJ 1998;317(7173):1624-9.
8. Mabry RL. Pharmacotherapy of allergic rhinitis: Corticosteroids. Otolaryngol Head Neck Surg 1995;113:120-5.
9. Jen A, Baroody F, deTineo M, et al. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2000;105:732-8.
10. Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989;83:627-33.
11. Ratner PH, van Bavel JH, Martin BG, et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 1998;47:118-25.
12. Pullerits T, Praks L, Skoogh BE, et al. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 1999;159:1814-18.
13. Benson M, Strannegard IL, Strannegard O, Wennergren G. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils. J Allergy Clin Immunol 2000;106:307-12.
14. Nielsen LP, Bjerke T, Christensen MB, et al. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season. Allergy 1998;53:778-85.
15. Talbot AR, Herr TM, Parsons DS. Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 1997;107:500-3.
16. Homer JJ, England RJ, Wilde AD, et al. The effect of pH of douching solutions on mucociliary clearance. Clin Otolaryngol 1999;24:312-15.
17. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope 2000;110:1189-93.
18. Homer JJ, Dowley AC, Condon L, et al. The effect of hypertonicity on nasal mucociliary clearance. Clin Otolaryngol 2000;25:558-60.
19. Shoseyov D, Bibi H, Shai P, et al. Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. J Allergy Clin Immunol 1998;101:602-5.
20. Heatley DG, McConnell KE, Kille TL, Leverson GE. Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg 2001;125:44-8.
21. Rabago D, Zgierska A, Mundt M, et al. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: A randomized controlled trial. J Fam Pract 2002;51:1049-55.
22. Min YG, Lee KS, Yun JB, et al. Hypertonic saline decreases ciliary movement in human nasal epithelium in vitro. Otolaryngol Head Neck Surg 2001;124:313-16.
23. Boek WM, Keles N, Graamans K, Huizing EH. Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope 1999;109:396-9.
24. Adam P, Stiffman M, Blake RL, Jr. A clinical trial of hypertonic saline nasal spray in subjects with the common cold orrhinosinusitis. Arch Fam Med 1998;7:39-43.
25. Even-Paz Z, Shani J. The Dead Sea and psoriasis. Historical and geographic background. Int J Dermatol 1989;28:1-9.
26. Nissenbaum A. Minor and trace elements in Dead Sea water. Chem Geol 1977;19:99-111.
27. Goldberg LH, Sagher F. Psoriasis treatment at the Dead Sea. Cutis 1975;16:61-2.
28. Schiffner R, Schiffner-Rohe J, Gerstenhauer M, et al. Dead Sea treatment-Principle for outpatient use in atopic dermatitis: Safety and efficacy of synchronous balneophototherapy using narrow-band UVB and bathing in Dead Sea salt solution. Eur J Dermatol 2002;12:543-8.
29. Levi-Schaffer F, Shani J, Politi Y, et al. Inhibition of proliferation of psoriatic and healthy fibroblasts in cell culture by selected Dead Sea salts. Pharmacology 1996;52:321-8.
30. Greiner J, Diezel W. [Inflammation-inhibiting effect of magnesium ions in contact eczema reactions]. Hautarzt 1990;41:602-5.
31. Keen JH. Intravenous magnesium sulfate for acute asthma. J Emerg Nurs 1995;21:44-6.
32. Ciarallo L, Sauer AH, Shannon MW. Intravenous magnesium therapy for moderate to severe pediatric asthma: Results of a randomized, placebo-controlled trial. J Pediatr 1996;129:809-14.
33. Rolla G, Bucca C, Bugiani M, et al. Reduction of histamine-induced bronchoconstriction by magnesium in asthmatic subjects. Allergy 1987;42:186-8.
34. Harari M, Barzillai R, Shani J. Magnesium in the management of asthma: Critical review of acute and chronic treatments, and Deutches Medizinisches Zentrum's (DMZ's) clinical experience at the Dead Sea. J Asthma 1998;35:525-36.
35. Mahajan PV, Rosenberg N, Sethuraman U, Dimitri H. Comparison of nebulized magnesium plus albuterol to nebulized albuterol alone in children with mild to moderate asthma. Presented at the annual meeting of the American Academy of Pediatrics; Oct. 19-23, 2002; Boston.
36. Hill J, Micklewright A, Lewis S, Britton J. Investigation of the effect of short-term change in dietary magnesium intake in asthma. Eur Respir J 1997;10:2225-9.
37. Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet 1994;344:357-62.
38. Garavello W, Romagnoli M, Sordo L, et al. Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: A randomized study. Pediatr Allergy Immunol 2003;14:140-3.
39. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999;104(2 Pt 1):364-9.
40. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996;98:843-5.
41. Ludwig P, Petrich K, Schewe T, Diezel W. Inhibition of eicosanoid formation in human polymorphonuclear leukocytes by high concentrations of magnesium ions. Biol Chem Hoppe Seyler 1995;376:739-44.
42. Chyrek-Borowska S, Obrzut D, Hofman J. The relation between magnesium, blood histamine level and eosinophilia in the acute stage of the allergic reactions in humans. Arch Immunol Ther Exp (Warsz) 1978;26:709-12.
43. Larbi KY, Gomperts BD. Complex pattern of inhibition by magnesium of exocytosis from permeabilised eosinophils. Cell Calcium 1997;21:213-19.